Immunome (IMNM) Institutional Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free IMNM Stock Alerts $15.50 +0.02 (+0.13%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Immunome (NASDAQ:IMNM)CurrentInstitutional OwnershipPercentage44.58%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$43.83MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.53M Get IMNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMNM Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Immunome Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024Acadian Asset Management LLC133,438$3.29M0.0%+602.1%0.223% 5/10/2024Vanguard Group Inc.2,019,738$49.85M0.0%+16.1%3.370% 5/9/2024 Lord Abbett & CO. LLC445,435$10.99M0.0%N/A0.743% 5/7/2024 Sei Investments Co.18,990$469K0.0%N/A0.032% 5/7/2024 Swiss National Bank71,400$1.76M0.0%N/A0.119% 5/1/2024 Capstone Investment Advisors LLC42,300$1.04M0.0%N/A0.071% Get the Latest News and Ratings for IMNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter. 4/26/2024 Clear Creek Financial Management LLC22,153$547K0.1%N/A0.037% 2/14/2024Avidity Partners Management LP1,333,479$14.27M0.5%N/A3.121% 2/13/2024Mayo Clinic108,480$1.16M7.2%N/A0.254% 2/7/2024Jump Financial LLC16,100$172K0.0%N/A0.038% 1/30/2024 Emfo LLC59,165$633K0.6%N/A0.138% 1/26/2024Cerity Partners LLC61,346$656K0.0%N/A0.144% 11/13/2023Acadian Asset Management LLC49,712$414K0.0%N/A0.407% 11/7/2023 Dorsey Wright & Associates3,100$26K0.0%N/A0.025% 10/27/2023 TD Asset Management Inc127,280$1.06M0.0%N/A1.043% 8/15/2023Prentice Capital Management LP112,131$887K2.8%-74.0%0.919% 8/2/2023Bank of Montreal Can100,334$800K0.0%N/A0.822% 7/12/2023Heron Bay Capital Management13,139$104K0.0%N/A0.108% 2/14/2023Susquehanna International Group LLP22,064$49K0.0%-9.2%0.182% 8/10/2022Cerity Partners LLC56,962$183K0.0%-39.1%0.470% 5/17/2022Prentice Capital Management LP792,321$4.50M1.1%-1.8%6.532% 11/16/2021Baldwin Investment Management LLC9,196$224K0.0%N/A0.076% 11/15/2021Marshall Wace LLP8,348$203K0.0%N/A0.069% 11/12/2021Geode Capital Management LLC54,669$1.33M0.0%+38.3%0.452% 11/10/2021HAP Trading LLC17,922$436K0.0%N/A0.148% 11/9/2021BlackRock Inc.40,508$986K0.0%+77.0%0.335% 10/25/2021Cerity Partners LLC102,004$2.48M0.1%-2.4%0.843% 10/20/2021 Ridgewood Investments LLC28,013$682K0.5%-51.7%0.232% 8/16/2021Royal Bank of Canada28,127$487K0.0%+8,271.1%0.239% 8/16/2021Morgan Stanley11,371$196K0.0%+9,375.8%0.097% 8/13/2021Renaissance Technologies LLC20,400$353K0.0%N/A0.174% 8/13/2021Alpine Global Management LLC854,671$14.79M2.0%+7.4%7.269% 8/13/2021Neuberger Berman Group LLC19,444$336K0.0%N/A0.165% 8/13/2021Geode Capital Management LLC39,529$683K0.0%-19.9%0.336% 8/13/2021Vanguard Group Inc.302,092$5.23M0.0%+95.9%2.569% 8/12/2021Ergoteles LLC10,006$173K0.0%N/A0.085% 8/9/2021Wealth Architects LLC11,201$194K0.0%N/A0.095% 8/6/2021 Magnus Financial Group LLC25,759$446K0.1%+75.9%0.219% 7/31/2021 Sterling Investment Advisors Ltd.21,627$374K0.1%N/A0.184% 7/31/2021 Ridgewood Investments LLC58,013$1.00M0.6%N/A0.493% Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here.5/18/2021Prentice Capital Management LP331,995$11.25M3.5%-20.3%2.824% 5/14/2021O Shaughnessy Asset Management LLC1,599$54K0.0%N/A0.015% 5/13/2021Alpine Global Management LLC795,709$26.96M2.6%+0.7%7.464% 5/12/2021Northern Trust Corp27,114$918K0.0%+7.2%0.254% 5/12/2021Cerity Partners LLC110,327$3.74M0.1%-10.0%1.035% 5/12/2021Geode Capital Management LLC49,331$1.67M0.0%+225.0%0.463% 5/11/2021 New York State Common Retirement Fund3,650$124K0.0%-33.0%0.034% 5/7/2021BlackRock Inc.112,851$3.82M0.0%+57.3%1.059% 5/5/2021 Magnus Financial Group LLC14,648$496K0.1%N/A0.137% 4/23/2021Strs Ohio1,400$47K0.0%N/A0.013% 2/19/2021JPMorgan Chase & Co.5,731$55K0.0%N/A0.054% 2/12/2021Prentice Capital Management LP416,667$4.03M1.1%N/A3.952% 2/12/2021Kepos Capital LP66,666$645K0.1%N/A0.632% 2/11/2021Northern Trust Corp25,287$245K0.0%N/A0.240% 2/11/2021Cerity Partners LLC122,546$1.19M0.0%N/A1.162% 2/8/2021 New York State Common Retirement Fund5,450$53K0.0%N/A0.052% 2/6/2021Granite Point Capital Management L.P.66,666$645K0.0%N/A0.632% 2/5/2021BlackRock Inc.71,752$695K0.0%N/A0.681% (Data available from 1/1/2016 forward) IMNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMNM shares? During the previous two years, 18 institutional investors and hedge funds held shares of Immunome. The most heavily invested institutionals were Vanguard Group Inc. ($49.85M), Avidity Partners Management LP ($14.27M), Lord Abbett & CO. LLC ($10.99M), Acadian Asset Management LLC ($3.29M), Swiss National Bank ($1.76M), Mayo Clinic ($1.16M), and TD Asset Management Inc ($1.06M).Learn more on IMNM's institutional investors. What percentage of Immunome stock is owned by institutional investors? 44.58% of Immunome stock is owned by institutional investors. Learn more on IMNM's institutional investor holdings. Which institutional investors have been buying Immunome stock? Of the 16 institutional investors that purchased Immunome stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avidity Partners Management LP ($1.33M), Lord Abbett & CO. LLC ($445.44K), Vanguard Group Inc. ($279.71K), Acadian Asset Management LLC ($164.15K), TD Asset Management Inc ($127.28K), Mayo Clinic ($108.48K), and Bank of Montreal Can ($100.33K). How much institutional buying is happening at Immunome? Institutional investors have bought a total of 2,866,558 shares in the last 24 months. This purchase volume represents approximately $43.83M in transactions. Which Immunome major shareholders have been selling company stock? The following institutional investors have sold Immunome stock in the last 24 months: Prentice Capital Management LP ($333.97K), Cerity Partners LLC ($36.58K), and Susquehanna International Group LLP ($2.24K). How much institutional selling is happening at Immunome? Institutional investors have sold a total of 372,793 shares in the last 24 months. This volume of shares sold represents approximately $2.73M in transactions. Related Companies: OCUL Institutional Ownership ABVX Institutional Ownership SPRY Institutional Ownership ARQT Institutional Ownership OPK Institutional Ownership PRAX Institutional Ownership TYRA Institutional Ownership SAVA Institutional Ownership ETNB Institutional Ownership ALXO Institutional Ownership This page (NASDAQ:IMNM) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.